Author's response to reviews Title: Adjuvant Interferon Gamma in Patients with Pulmonary Atypical Mycobacteriosis: a Randomized, Double-blind, Placebo-Controlled Study. Authors:

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

BACKGROUND High antibiotic resistance is described in atypical Mycobacteriosis, mainly by Mycobacterium avium complex (MAC). METHODS A randomized, double-blind, placebo-controlled clinical trial was carried out in two hospitals to evaluate the effect of interferon (IFN) gamma as immunoadjuvant to chemotherapy on patients with atypical mycobacteria lung disease. Patients received placebo or 1 ...

Author's response to reviews Title: Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: A randomized double-blind, placebo-controlled study Authors:

Title: Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: A randomized double-blind, placebo-controlled study

Author's response to reviews Title: Effect of exercise training and dopamine agonists in patients with uremic Restless Legs Syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study Authors:

Author's response to reviews Title: Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study Authors:

Author's response to reviews Title: Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial. Authors:

Title: Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial.